Analyst firms · Leerink Partners · RAPT

Leerink Partners RAPT price target and rating history

RAPT Therapeutics Inc. (RAPT) · Health Care

Leerink Partners rates RAPT Therapeutics Inc. (RAPT) Outperform with a $37 price target, as of its latest action on Sep 26, 2025. It has published 3 rating actions on RAPT since August 2021, including 1 upgrade and 1 downgrade.

Current rating
Outperform
Price target
$37
Median target, all firms
Too few
Actions on RAPT
3

Leerink Partners price target on RAPT

$49$30$1020222023202420252026
Leerink Partners price target on RAPT, each point a stated target, August 2021 to September 2025.

Every Leerink Partners rating on RAPT

Questions about Leerink Partners and RAPT

What is Leerink Partners's price target for RAPT?
Leerink Partners's latest stated price target for RAPT Therapeutics Inc. (RAPT) is $37, from its action on Sep 26, 2025.
What is Leerink Partners's rating on RAPT?
Leerink Partners rates RAPT Outperform, a bullish rating, as of Sep 26, 2025.
When did Leerink Partners last change its view on RAPT?
On Sep 26, 2025, Leerink Partners upgrades to Outperform from Market Perform, price target $37.

More RAPT rating histories

All Leerink Partners ratingsRAPT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.